Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: ALCON (NYSE: ACL) Profitability
Reply New Message
Back To Forum List View

ALCON (NYSE: ACL) Profitability

posted on Sep 10, 2009 02:29PM

A large licence fee to us is but a drop in the bucket to them!

Market cap

$40.24B

Gross margin (TTM)

79.70%

Operating margin (TTM)

39.00%

Profit margin (TTM)

32.50%

Share Price

$135

3 Recommendations
Re: ALCON (NYSE: ACL) Profitability
1
on2u
Sep 10, 2009 02:53PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply